The VIBLOK SAfety and perFormancE Trial

NCT03080961 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

HSV-2 Infection
Genital Herpes

Interventions

DEVICE: VIBLOK barrier cream

Sponsor

CLJI Worldwide

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]